Clinical trial
A Randomized Phase II Evaluation of Continuous Progestin Therapy vs. Sequential Progestin Therapy in the Treatment of Endometrial Intraepithelial Neoplasia (EIN) From a Referred Cohort of Atypical Endometrial Hyperplasia (AEH) or EIN Patients That Desire Uterine Preservation
NCT00503581 is registered in ClinicalTrials.gov with Gynecologic Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Phase II Evaluation of Continuous Progestin Therapy vs. Sequential Progestin Therapy in the Treatment of Endometrial Intraepithelial Neoplasia (EIN) From a Referred Cohort of Atypical Endometrial Hyperplasia (AEH) or EIN Patients That Desire Uterine Preservation
- Lead sponsor
- Gynecologic Oncology Group
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- July 31, 2007
- Completion date
- Not reported
- Enrollment
- 9 (actual)
- Sites
- 50
Conditions
As the registry lists them; a condition with its own page is linked.
high grade squamous intraepithelial neoplasia, stage 0 uterine corpus cancer